Literature DB >> 2719427

Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS).

P S Gill1, C Loureiro, M Bernstein-Singer, M U Rarick, F Sattler, A M Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2719427     DOI： 10.7326/0003-4819-110-11-937

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  33 in total

Review 1.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

2.  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

Authors:  Harriet Mayanja-Kizza; Edward Jones-Lopez; Alphonse Okwera; Robert S Wallis; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  J Infect Dis       Date:  2005-02-08       Impact factor: 5.226

Review 3.  Oral candidiasis, HIV, and saliva glucocorticoids.

Authors:  C O Enwonwu; V I Meeks
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

4.  Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma.

Authors:  S Nagpal; J Cai; T Zheng; S Patel; R Masood; G Y Lin; S Friant; A Johnson; D L Smith; R A Chandraratna; P S Gill
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients.

Authors:  J G Hakim; I Ternouth; E Mushangi; S Siziya; V Robertson; A Malin
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

Review 6.  HIV-Associated Cancers and Related Diseases.

Authors:  Robert Yarchoan; Thomas S Uldrick
Journal:  N Engl J Med       Date:  2018-03-15       Impact factor: 91.245

7.  Effect of interferon alpha on high serum androgen concentrations in HIV positive men with Kaposi's sarcoma.

Authors:  N Christeff; S Gharakhanian; N Thobie; E Wirbel; M T Dalle; D Costagliola; E A Nunez; W Rozenbaum
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

8.  Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.

Authors:  Thomas S Uldrick; Mark N Polizzotto; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Denise Whitby; Victoria Wang; Stefania Pittaluga; Deirdre O'Mahony; Seth M Steinberg; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

9.  Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.

Authors:  Zhiqiang Qin; Lu Dai; Michael Defee; Victoria J Findlay; Dennis K Watson; Bryan P Toole; Jennifer Cameron; Francesca Peruzzi; Keith Kirkwood; Chris Parsons
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

10.  A case of exogenous corticosteroid-induced Kaposi's sarcoma that developed after a cure of endogenous hypercortisolism.

Authors:  Soyeon Yoo; Shinhang Moon; Sang-Ouk Chin; Sang-Ah Lee; Changlim Hyun; Gwanpyo Koh
Journal:  Int J Clin Pharm       Date:  2015-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.